Evidence map›Paper›PMID 28691783›Full record

ArticleAngewandte Chemie (International ed. in English)2017

Two-Step Synthesis of Complex Artificial Macrocyclic Compounds.

Rudrakshula Madhavachary, Eman M M Abdelraheem, Arianna Rossetti, Aleksandra Twarda-Clapa, Bogdan Musielak, Katarzyna Kurpiewska, Justyna Kalinowska-Tłuścik, Tad A Holak, Alexander Dömling

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Multicomponent Macrocyclic IL-17a Modifier.ACS medicinal chemistry letters · 2022
    Article
  2. Article
  3. Benchmark of Generic Shapes for Macrocycles.Journal of chemical information and modeling · 2020
    Article
  4. Article
  5. Article
  6. Structure and Reactivity of Glycosyl Isocyanides.European journal of organic chemistry · 2019
    Article
  7. Design of indole- and MCR-based macrocycles as p53-MDM2 antagonists.Beilstein journal of organic chemistry · 2019
    Article
  8. Artificial Macrocycles.Synlett : accounts and rapid communications in synthetic organic chemistry · 2018
    Article
  9. Article
  10. Article
  11. Two-Step Macrocycle Synthesis by Classical Ugi Reaction.The Journal of organic chemistry · 2018
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rudrakshula MadhavacharyDrug Design, University of Groningen, Address Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Eman M M AbdelraheemDrug Design, University of Groningen, Address Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Arianna RossettiDrug Design, University of Groningen, Address Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Aleksandra Twarda-ClapaFaculty of Chemistry, Jagiellonian University, 3 Ingardena Street, 30-060, Krakow, Poland.
Bogdan MusielakFaculty of Chemistry, Jagiellonian University, 3 Ingardena Street, 30-060, Krakow, Poland.
Katarzyna KurpiewskaFaculty of Chemistry, Jagiellonian University, 3 Ingardena Street, 30-060, Krakow, Poland.
Justyna Kalinowska-TłuścikFaculty of Chemistry, Jagiellonian University, 3 Ingardena Street, 30-060, Krakow, Poland.
Tad A HolakFaculty of Chemistry, Jagiellonian University, 3 Ingardena Street, 30-060, Krakow, Poland.
Alexander DömlingDrug Design, University of Groningen, Address Deusinglaan 1, 9713 AV, Groningen, The Netherlands.ORCID 0000-0002-9923-8873

Funding

Real-time discovery of inhibitors among billion compounds for preview and downloadR01GM097082 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CAMACHO, CARLOS J. · 2011 to 2020
$2.5M
NIGMS NIH HHS R01 GM097082
6 · The paper itself

Abstract

The design and synthesis of head-to-tail linked artificial macrocycles using the Ugi-reaction has been developed. This synthetic approach of just two steps is unprecedented, short, efficient and works over a wide range of medium (8-11) and macrocyclic (≥12) loop sizes. The substrate scope and functional group tolerance is exceptional. Using this approach, we have synthesized 39 novel macrocycles by two or even one single synthetic operation. The properties of our macrocycles are discussed with respect to their potential to bind to biological targets that are not druggable by conventional, drug-like compounds. As an application of these artificial macrocycles we highlight potent p53-MDM2 antagonism.

Indexed as

Macrocyclic CompoundsMolecular StructureMacrocyclic Compoundsdrug discoverymacrocyclesprotein-protein interactionssynthetic methodsUgi reaction

Identifiers

PMID28691783
PMCPMC5660312

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.